About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Fuji Pharma Co.,Ltd.(4554) Financial Results

4554
TSE Prime
Fuji Pharma Co.,Ltd.
1,559
JPY
+10
(+0.65%)
Dec 23, 3:30 pm JST
9.95
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
ー
ー
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2021 33,990 3,349 3,250 2,432 90.5 29 Nov 5, 2021 J-GAAP
Sep, 2022 35,426 3,777 3,725 2,696 111.0 35 Nov 10, 2022 J-GAAP
Sep, 2023 40,889 3,858 4,519 3,435 141.4 37 Nov 9, 2023 J-GAAP
Sep, 2024 46,138 3,880 4,445 6,146 252.9 42.50 Nov 12, 2024 J-GAAP
Sep, 2025 Guidance 53,360 4,850 4,680 3,380 139.0 45.50 Nov 12, 2024 J-GAAP
YoY +15.7% +25.0% +5.3% -45.0% -45.0%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 46,138 4,391 4,628 6,146 252.9
Fiscal Year Sep, 2024 Sep, 2018 Sep, 2017 Sep, 2024 Sep, 2024
First Half
Result
Guidance History
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2021 17,726 2,712 2,866 1,834 75.5 15 May 6, 2022 J-GAAP
Oct - Mar, 2022 19,225 1,824 2,456 1,772 73.0 17 May 11, 2023 J-GAAP
Oct - Mar, 2023 21,388 1,443 2,165 4,257 175.2 20 May 9, 2024 J-GAAP
Oct - Mar, 2024 Guidance 26,150 2,380 2,330 1,650 67.9 20 Nov 12, 2024 J-GAAP
YoY +22.3% +64.9% +7.6% -61.2% -61.3%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Sep, 2022 3,777 -11,929 -658 -11,271 5,094 3,546 4.69 J-GAAP
Sep, 2023 3,858 -3,323 1,917 -5,240 1,915 2,324 2.72 J-GAAP
Sep, 2024 3,880 2,493 4,151 -1,658 -435 4,585 5.09 J-GAAP
Actual Performance and Financial Trends
Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2022 35,426 3,777 3,725 2,696 111.0 35 Nov 10, 2022 J-GAAP
Sep, 2023 40,889 3,858 4,519 3,435 141.4 37 Nov 9, 2023 J-GAAP
Sep, 2024 46,138 3,880 4,445 6,146 252.9 42.50 Nov 12, 2024 J-GAAP
YoY +12.8% +0.6% -1.6% +78.9% +78.9%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 9,996 1,190 1,579 1,114 45.9 11.9 Feb 9, 2023 J-GAAP
Jan - Mar, 2023 9,229 634 877 658 27.1 6.9 May 11, 2023 J-GAAP
Apr - Jun, 2023 10,257 579 285 210 8.6 5.6 Aug 8, 2023 J-GAAP
Jul - Sep, 2023 11,407 1,455 1,778 1,453 59.8 12.8 Nov 9, 2023 J-GAAP
Oct - Dec, 2023 10,746 -140 -96 2,739 112.7 -1.3 Feb 8, 2024 J-GAAP
Jan - Mar, 2024 10,642 1,583 2,261 1,518 62.5 14.9 May 9, 2024 J-GAAP
Apr - Jun, 2024 11,767 772 802 653 26.9 6.6 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 12,983 1,665 1,478 1,236 50.9 12.8 Nov 12, 2024 J-GAAP
YoY +13.8% +14.4% -16.9% -14.9% -15.0%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 12,983 1,725 2,261 2,739 112.7
Fiscal Year Sep, 2024 Dec, 2017 Mar, 2024 Dec, 2023 Dec, 2023
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Sep, 2022 1,473.73 47.4 75,538 35,803 26,546 0.69 Nov 10, 2022 J-GAAP
Sep, 2023 1,694.23 48.3 85,332 41,174 29,082 0.70 Nov 9, 2023 J-GAAP
Sep, 2024 1,873.52 50.6 90,000 45,549 34,256 0.64 Nov 12, 2024 J-GAAP